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Objective To synthesize the literature on the effect of provision of personalised cancer risk 
information to individuals at population level risk on accuracy of risk perception and 
psychological responses. 
Methods A systematic review and random effects meta-analysis of articles published from 
01/01/2000 to 01/07/2017. 
Results We included 23 studies. Immediately after provision of risk information 87% of 
individuals were able to recall the absolute risk estimate. Less than half believed that to be 
their risk, with up to 71% believing their risk to be higher than the estimate. Provision of risk 
information increased accuracy of perceived absolute risk immediately after risk information 
compared with no information (pooled RR 4.16 (95%CI 1.28-13.49), 3 studies). There was no 
significant effect on comparative risk accuracy (pooled RR 1.39 (0.72-2.69), 2 studies) and 
either no change or a reduction in cancer worry, anxiety and fear.  
Conclusion These findings highlight the complex cognitive processes involved in the 
conceptualisation of risk.  
Practice implications Individuals who appear to understand and are able to recall risk 
information most likely do not believe it reflects their own risk. 
 





An increasing number of risk models are now available that enable estimation of an 
individual’s future risk of cancer. Although providing individuals with a personalised risk 
estimate in isolation is unlikely to lead to behaviour change[1,2], personalised risk 
communication may complement educational interventions and increase motivation and 
health-related behaviour change over and above risk factor awareness education and lifestyle 
advice alone[3]. There is also increasing interest in the potential benefits of incorporating risk 
stratification into cancer screening programmes to enable the screening frequency, modality, 
and/or eligible age range to be adjusted to potentially optimise the benefit-harm ratio[4]. 
However, the general population does not easily understand the concept of risk[5,6], 
with lay perceptions of risk often being resistant to change and differing substantially from 
those of experts[7]. These discrepancies are potentially consequential. Risk perception, 
particularly when assessed using high quality measures, has been shown to predict 
behaviour[8], and cancer risk perception specifically is associated with health-related quality 
of life, depression, anxiety and cancer worry[9–11]. Understanding the impact of providing 
personalised cancer risk information on perceptions of risk and psychological responses is, 
therefore, important.  
Previous reviews have shown that provision of cancer-based risk information in 
genetic counselling centres can increase accuracy of risk perception while leading to either no 
change in psychological outcomes or psychological benefits[12–14]. Individuals attending 
genetic counselling centres, however, are typically referred by healthcare professionals due to 
a family or personal history of cancer. These individuals are, therefore, already aware that 
they are potentially at high risk and their responses to risk information may differ from those 
at population level risk. To inform future population-based communication of cancer risk, we 
aimed to synthesise the effects of interventions incorporating non-genetic personalised cancer 
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risk information on accuracy of risk perception and psychological responses in individuals 
not already identified as at high risk on the basis of a personal or family history of cancer or 
following referral to specialist cancer risk services. 
2. Methods 
We performed a systematic literature review following an a priori established study protocol 
(available on request). Reporting followed the PRISMA statement[15]. 
2.1 Search strategy 
We used the same search strategy as for a previous review of the effect of interventions 
incorporating personalised cancer risk information which focused on intentions and 
behaviour[16]. This included an electronic literature search of Medline, EMBASE, CINAHL 
and PsycINFO from 1st January 2000 until 1st July 2017 with no language limits, using a 
combination of subject headings and free text incorporating ‘cancer’, ‘risk/risk factor/risk 
assessment’ and ‘prediction/model/score/tool’ (see Appendix File A.1 for the complete 
search strategies). We manually screened the reference lists of all included papers to identify 
additional papers. As the outcomes of interest for this review are not collected routinely 
within healthcare and both CINAHL and PsycINFO include citations to books, reports, 
dissertations and theses, we did not specifically search for additional grey literature.   
2.2 Study selection 
We included studies if they met the following criteria: 1) were published as a primary 
research paper in a peer-reviewed journal; 2) included adults with no previous history of 
cancer; 3) included provision to individuals of a personal estimate of future cancer risk based 
on two or more non-genetic variables, either alone or as part of a larger intervention; and 4) 
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included data on either accuracy of risk recall or risk perception at the level of the individual 
or psychological measures (including cancer worry, anxiety, depression, affect and quality of 
life). As in our previous review[16], in order to focus on the provision of personalised cancer 
risk information to the general population, we excluded studies which had recruited 
participants on the basis of a personal or family history of cancer or following referral to 
specialist cancer risk services. We also excluded vignette studies, qualitative studies, 
conference abstracts, editorials, commentaries and letters.  
Two reviewers (JUS and BS) each screened half of the titles and abstracts to exclude 
papers that were clearly not relevant. A third reviewer (SG) independently assessed a random 
selection of 5% of the papers screened by each of the first reviewers. The full text was 
examined by two reviewers (MB and MF) independently if a definite decision to exclude 
could not be made based on title and abstract alone. A third reviewer (JUS) then assessed all 
those for which it was unclear at full text level whether or not the inclusion criteria were met.  
2.3 Data extraction  
At least two researchers (JUS/BS/MB/MF) independently extracted data from studies 
included in the review directly into data tables. This included data on: (1) study 
characteristics (cancer type, study design, study setting, duration of follow-up); (2) selection 
of participants (inclusion criteria, method of recruitment/randomisation); (3) participant 
characteristics (age, level of cancer risk, sample size); (4) the intervention (risk tool used, 
method and format of risk communication, additional information or follow-up provided), 
and (4) measured outcome(s). Reviewers were not blinded to publication details. If numerical 




2.4 Quality assessment 
Quality assessment was performed by two reviewers (MB and MF) using a checklist based on 
the Critical Appraisal Skills Programme (CASP) guidelines[17]. This includes eight 
questions concerning whether the study addressed a clearly focused issue, the method of 
recruitment and randomisation, whether blinding was used, the measurement of the exposure 
and outcome, the comparability of the study groups and the follow-up. Each study was then 
classified as high, medium or low quality. We did not exclude any studies based on quality 
alone.  
2.5 Data synthesis and statistical analysis 
As data on psychological outcomes (worry, anxiety, fear, depression and quality of life) used 
different measurement scales and variably reported change from baseline to follow-up and 
mean values at follow-up, it was only possible to pool results for accuracy of risk perception. 
For the comparison between risk information and no information we used random effects 
meta-analysis[18] and the ‘metan’ package in Stata and present intervention effects as 
relative risk (RR) rather than odds ratios (OR) to avoid overestimating the risk[19]. If there 
were zero participants in any group, we added 0.5 to each of the cells of the 2x2 table in both 
the control and intervention group[20]. For the study by Timmermans et al.[21] in which data 
were reported for accuracy in the same participants for colon cancer and lung cancer 
separately, we included only the results for colon cancer in the meta-analysis to avoid 
including the same participants twice in the same analysis. The results were similar when 
lung cancer was included instead (data not shown). To pool the percentage who were able to 
recall the risk information provided to them accurately and those whose risk perception 
accurately matched the risk estimate that they had been provided we also used the ‘metan’ 
package in Stata with a random effects model. In both cases we quantified the heterogeneity 
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between studies using the I2 statistic. All analyses were conducted using statistical software 
package Stata/SE version 14.  
3. Results 
As reported previously[16], we identified 35,802 unique papers from the electronic search. 
Of these, 35,604 were excluded at title and abstract level. After screening by the first 
reviewer (JUS/BS), no additional papers met the inclusion criteria in the random 5% screened 
by the second reviewer (SG). A further 180 were excluded after full-text assessment against 
the inclusion and exclusion criteria specific for this review question. The most common 
reasons for exclusion at this stage were that the papers did not include provision of a personal 
risk estimate (n=69), did not include any data on predefined outcomes (n= 32), were 
conference abstracts (n=20), or were not primary research (n=16) (Figure 1). We identified 
four additional papers through citation searching, leaving us with 22 papers describing 23 
studies in the analysis. [Insert Figure 1 near here] 
Table 1 summarises the design, setting and key outcomes of the 23 included studies 
and Table 2 provides additional details about the tools used to estimate the personalised risk 
and the format in which the risk information was provided. The majority (n=15) focused on 
provision of breast cancer risk derived from the Gail model[22], four provided risk 
information about colorectal cancer, one lung cancer, one cervical cancer, one colorectal and 
lung cancer, and one colorectal, breast and ovarian cancer. All but two studies[23,24] were 
conducted in the USA. Twelve were assessed as high or medium/high quality, seven as 
medium quality and four as medium/low based on the CASP guidelines (Appendix File A.2). 
[Insert Table 1 near here][25–30] 
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3.1 Recall of risk information 
Three studies reported recall of absolute risk[31–33]. Immediately after being provided with 
risk information, 87% (95% CI 84% to 91%, I2 = 0%) of those given absolute risk 
information were able to recall their numerical absolute risk estimate accurately (defined as 
exact agreement)(Figure 2), with no difference between those presented risk of breast cancer 
as either a point estimate on a 0-100% scale, as a range, or as a point estimate plus a 
range[33]. Comparative risk, where individuals were provided with estimates of their risk in 
comparison with others, was reported in only one study where 64% were accurate[31]. [Insert 
Figure 2 near here] 
Two of these studies additionally compared recall of risk information and risk 
perception. In the study by Lipkus et al. only 17% (n=19/102) of those who were able to 
recall their risk estimate perceived that to be their risk within 0.5%, with 71% (n=72/102) 
believing their risk to be higher and 12% (n=12/102) their risk to be lower[32]. Similarly, in 
Weinstein et al., those who had received absolute risk information gave the same answer for 
their own beliefs as their recollection of what they had been told only 45% of the time, giving 
a higher value for their own beliefs 47% of the time and a lower value 8% of the time[31]. 
Corresponding percentages for comparative information were 39%, 46% and 15% 
respectively. A further study did not compare recall with perceived risk but instead asked 
women at a follow-up telephone interview how they would compare their actual risk with the 
estimate provided in the study. 53% thought that their actual risk was ‘just the same,’ while 
38% thought that their risk was greater than what they had been told.[34] 
3.2 Accuracy of risk perception  
Thirteen studies reported data on accuracy of risk perception. Eight of these reported 
accuracy as the agreement between the perceived risk estimates participants gave and the 
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estimated personalised risks they had been presented with. The other five studies reported 
accuracy indirectly, either as the extent of overestimation or the change in risk perception in 
groups known to all either over-estimate or under-estimate their risk at baseline.  
Definitions of what constituted “accurate” and the time interval between provision of 
risk information and follow-up varied widely between studies (Table 3). This made pooling 
many of the results inappropriate. It was possible, however, to pool data from three studies 
that measured accuracy of absolute or comparative risk perception immediately after 
provision of risk information about colon cancer compared with no information[21,31,35]. 
Those who received both absolute and comparative risk estimates were more likely to have 
accurate absolute risk perceptions immediately post risk information (pooled RR 2.59 (1.40 
to 4.81) I2=81.2%) (Figure 3), with no difference between those provided with absolute risk 
alone or absolute plus comparative risk (data not shown). There was no significant effect on 
comparative risk accuracy (pooled RR 1.11 (0.74 to 1.66) I2=82.9%) (Figure 3).  [Insert 
Figure 3 near here] 
Despite these improvements in accuracy compared to control groups, even 
immediately after risk information, up to half of all participants remained inaccurate (pooled 
percentage for absolute risk accuracy 44% (31% to 56%, I2 = 91.5) and for comparative risk 
40% (95% CI 36% to 44%) (Figure 4). [Insert Figure 4 near here] 
The findings from these and the other studies that could not be pooled are summarised 
in Table 3. Overall, eight showed improvements in accuracy, two no effect and three mixed 
results. One study directly compared the effect of alternative formats on risk accuracy. In that 
study, Emmons et al. showed that those who were randomised to have the opportunity to see 
how adopting or changing any of the risk factors would impact on their total risk profile had 
greater improvement in accuracy immediately post information for both comparative and 
absolute risk accuracy compared to those who did not[35]. A further study assessed the role 
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of numeracy and found that among women with an estimated risk <1.5%, the degree to which 
participants overestimated their risk was moderated by numeracy, with women with high 
numeracy having greater increases in accuracy than women with low numeracy[36]. No 
significant moderation effects were seen for women with an estimated risk ≥1.5%.  
Having the opportunity to see how changing any of the risk factors would influence 
their risk, as well as inclusion of social comparison information[37], appeared to be 
associated with greater improvements in accuracy of perceived risk. By comparison no 
differences were seen for providing pre-intervention risk estimates, self-affirmation, 
providing data so that individuals believed that all factors they considered possibly 
responsible for their own risk were used to compute their risk[37], or with race or education 
level[38,39].  
3.3 Psychological responses 
3.3.1 Cancer specific worry, anxiety or fear 
Thirteen randomised controlled trials (RCTs) reported cancer specific worry, anxiety or fear. 
As the studies used different scales and variably reported change from baseline to follow-up 
and mean values at follow-up, it was not possible to pool the studies. Instead, the findings are 
summarised in Table 4. Ten reported no significant change and three a reduction. 
3.3.2 General anxiety, depression, affect and health-related quality of life 
Three studies reported general anxiety using versions of the Spielberger State Anxiety 
Inventory (STAI)[40]. Two RCTs showed non-statistically significant differences between 
women randomised to receive personalised estimates of the risk of cervical cancer during 
cervical screening appointments or routine care (-1.6 (95%CI: -3.5 to 0.2), p=0.084)[23] and 
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among 314 participants randomised to complete a self-administered decision aid for 
colorectal cancer (CRC) screening which included personalised information on risk of 
developing CRC or to receive a booklet about the Australian CRC screening guidelines[41]. 
The third study by van Erkelens et al.[42] measured anxiety using a Dutch version of the 
STAI alongside the Hospital Anxiety Depression Scale before and two weeks after 287 
women had completed an online self-test that identified those at increased Familial Breast 
Cancer risk based on the Dutch breast cancer guidelines. It was the only study to report 
results separately for women at population risk and those at moderate (relative risk ≥2-3) or 
high risk (relative risk >4) of breast cancer. In women at population risk of breast cancer 
(n=272), state-anxiety significantly decreased immediately after taking the test (mean change 
from baseline -2 (95% CI -2 to -1), p<0.001) and both state anxiety and trait anxiety 
significantly decreased at two weeks (mean change from baseline -3 (95% CI -5 to -2) and -1 
(95% CI -2 to -1) respectively, p for both ≤0.002). There was no change in distress among 
those participants at two weeks and no significant changes in any outcomes in the 15 women 
at increased familial breast cancer risk.  
Affect was measured in one RCT using the Positive and Negative Affect Scale 
(PANAS)[43] in which female undergraduates received absolute risk feedback with or 
without comparative information[37]. No significant between-group differences in affect 
were observed. Health-related quality of life was additionally measured in two RCTs[44,45] 
using the SF-36[46]. Both reported a significant increase in score on the SF-36 at follow-up 
in the intervention group compared with the control group. 
4. Discussion and Conclusion 
4.1 Discussion 
This study is, to our knowledge, the first comprehensive review of the impact of interventions 
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incorporating provision of personalised cancer risk information based on non-genetic risk 
factors on accuracy of risk perception and psychological responses among individuals at 
population level risk. A particularly novel aspect is that in the synthesis we have been able to 
distinguish between recall of risk information and risk perception and have shown that, while 
immediately after provision of risk information 87% of individuals were able to recall the 
absolute risk estimate, less than half believed that to be their risk, with up to 71% believing 
their risk to be higher than the estimate. These findings in particular highlight the conceptual 
problems in understanding risk information and the tendency for people to resist information 
that is communicated to them by experts that have previously been reported across both 
cancer and other diseases[5]. Among these, qualitative studies have shown that risk 
perception is not as simple as recalling a number and that the processing of risk information 
is not purely ‘rational’ or ‘objective’[47]. Instead, an individual’s perception of risk is based 
on a complex integration of cognitive and social biases arising from cultural, personal or lay 
theories of disease and risk, and past experiences, expectations and beliefs[32,34,47–52]. The 
studies included in this review support the view that, rather than simply replacing their prior 
beliefs concerning their risk of developing cancer with new information, individuals appear 
instead to be using the new risk information to update their prior beliefs, analogous to 
Bayesian inference. The extent to which individuals over- or under-estimate their risk at 
baseline decreases after provision of risk information (reflected by an increase in accuracy) 
but many individuals continue to, in most cases, overestimate their risk.  
The complex cognitive processes involved in this conceptualisation of risk may in 
part also explain our finding that risk-based inventions improve accuracy of absolute risk 
perception but not comparative risk. By its very nature comparative risk is a more emotive 
and less abstract construct[8]. It may therefore be more prone to cultural, cognitive and social 
biases and in turn more resistant to change. For the same reasons, however, comparative risk 
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may sometimes play a more important role in influencing decisions concerning health 
behaviours.  
The observed discrepancy between the risk estimate and perceived risks may also 
reflect varying levels of numeracy and the difficulties people often have understanding risk 
information[53,54]. This is supported by the finding in this review that among women with 
an estimated risk <1.5%, those with high numeracy had greater increases in accuracy than 
those with low numeracy[36]. Numerical misunderstanding was also given as a reason for 
feeling that their risk was higher or lower  by women who recalled their risk estimate 
correctly but gave a different response when asked about their perceived risk in the study by 
Lipkus et al.[32].  
The finding that individuals tend to overestimate their risk prior to receiving risk 
information and that provision of risk information has no effect or reduces cancer worry, 
anxiety and depression has also been reported for other diseases, including diabetes[55] and 
cardiovascular disease[56], and following communication of genetic risk[13,57]. Cancer 
specific worry has been reported to predict engagement in prevention initiatives[58]. This 
observed reduction in cancer worry, anxiety and fear may in part, therefore, explain the lack 
of association between provision of risk information and behaviour change[16].  
These findings must however be interpreted within the limitations of this review. We 
performed it following accepted best practice with independent screening of full-text articles 
for inclusion and double data extraction and quality assessment[15]. Nevertheless, there are a 
number of limitations. Firstly, while we screened over 35,000 articles from four electronic 
databases and the reference lists of included articles, we did not specifically search for 
additional grey literature and were unable to assess publication bias formally. It is therefore 
possible that there are additional studies of relevance to this review question that we did not 
include. Given the number of articles screened and the high proportion of those with negative 
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findings, however, we think it unlikely that these would change the overall findings.  
Secondly, the design of the included studies, definitions of accuracy of risk perception, and 
the range of ways in which psychological outcome measures were collected and reported 
varied substantially. For example, the 23 included studies incorporated 12 different measures 
of risk accuracy and eight of worry. This range of measures has been reported 
previously[12,14] and made summarising and pooling the findings difficult and meant we 
were only able to include a small number of the studies in the meta-analysis, limiting the 
strength of those results. This was further limited by many of the included studies also only 
presenting data for outcomes where significant changes had been observed, including only a 
statement of no change for other outcomes. Thirdly, risk was communicated to individuals in 
different formats and many of the interventions included written or verbal information 
alongside risk estimates. Isolating the effect of the risk information or any differences 
between formats was not possible. This is likely to have less of an impact on the measures of 
risk perception but may have influenced the psychological outcomes. Fourteen of the 23 
studies also looked at breast cancer, all but two were in the US and all were at risk of 
potential recruitment bias. Together these limit the generalisability of the findings. 
Particularly for accuracy of risk perception, most of the studies only reported outcomes either 
immediately or a few weeks after provision of risk information. The findings therefore 
largely reflect the short term impact of provision of risk information. 
4.2 Conclusion 
This review shows that immediately after provision of risk information 87% of individuals 
were able to recall the absolute risk estimate that they had been given. However, less than 
half believed that to be their risk, with up to 71% believing their risk to be higher than the 
given estimate. Provision of risk information increased accuracy of perceived risk 
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immediately after risk information and reduced mean perceived risk among groups who 
overestimated their risk at baseline. However over half of individuals remained inaccurate, 
with most perceiving their risk as higher than the risk estimate that they had been provided 
with. By comparison, there was no significant effect on comparative risk accuracy, either 
immediately or in the short/medium term and either no effect or a reduction in worry, anxiety 
or depression, with no evidence of differences with age, race, level of education or 
presentation of risk.  
The review itself also highlights a number of important messages for researchers. 
These include the need for: consistent measures of risk accuracy and psychological responses 
to facilitate comparison across studies; sub-group analyses, particularly for psychological 
responses, in individuals who over-estimate or under-estimate their risk at baseline; studies 
including other cancer types,  outside the US, and among men and people of diverse 
socioeconomic and cultural groups to improve the generalisability of the results; and better 
reporting of negative results. Attempting to measure risk perception with a single number is 
also unlikely to capture the complex cognitive processes involved in the conceptualisation of 
risk. Researchers should therefore consider using broader risk perception instruments, such as 
the Tripartite model of risk perception which includes assessment of susceptibility to disease 
(deliberative risk perception) alongside  measures of the affective and experiential 
components of risk perception, including cancer-specific worry, anxiety and fear[59]. Not 
only is this model more likely to capture the range of cognitive processes, but it has been 
shown to predict intention to change health-related behaviour more accurately than 
unidimensional models of risk perception. Risk conviction, the subjective sense of certainty 
that one knows what one’s perceived risk is and the confidence that this risk perception is 




4.3 Practice Implications 
Perhaps the most important message from this review for clinical practice is the recognition 
that individuals who appear to understand and be able to recall risk information provided to 
them most likely do not believe that the risk information reflects their own risk. As described 
above, the reasons for this are complex and, as a result, are unlikely to be specific to cancer 
or overcome within a single consultation or by a single intervention. However, by being 
aware of the limits of provision of information and cognisant of the context in which each 
person is using the information to construct an individual perception of risk, clinicians will be 
better able to tailor the explanations of risk to their patients and support their understanding 
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Figure 1. PRISMA Flow diagram 
Figure 2. Forest plot showing the percentage of participants able to accurately recall the 
absolute risk estimate immediately after receiving risk information. 
Figure 3. Forest plot showing the relative risk of having an accurate perception of absolute or 
comparative risk immediately after receiving it compared to controls who did not receive risk 
information. 
Figure 4. Forest plot showing the percentage of participants who had an accurate perception 

















Breast RCT 6 and 24 
months 
150 sexual minority women recruited via public 
advertisements 
Mean Gail 
lifetime risk 12% 
Quality of life and cancer worry H 
Bowen 
2010 
Breast RCT 12 
months 
1,366  women recruited via telephone with no 
previous diagnosis of breast cancer 
Mean Gail 
lifetime risk 12% 
Quality of life H 
Davis, 
2004 
Breast RCT 1 month 392 women with no history cancer calling the 
Cancer Information Service  
27% 2-6% 
lifetime risk; 32% 
6-9% lifetime 
risk; 41% 9-46% 
lifetime risk 





Breast RCT 0, 2 
weeks 
Convenience sample of 72 female 
undergraduates with no first degree relatives 
with breast cancer 





Breast RCT 0, 2 
weeks 
Convenience sample of 62 female 
undergraduates with no first degree relatives 
with breast cancer 
Not given Accuracy of risk perception, positive 




Colorectal RCT 0 353 patients with no history of cancer scheduled 
for routine or non-urgent health care visits to 
two primary care practices 
Mean 20 year risk 
9.96 per 1,000 





Breast RCT 3 
months 
Random sample of 340 members of state 
healthcare system with no history of 
breast/ovarian cancer or testing for cancer risk 
Mean 9.5% (3.2) 
lifetime risk 





Cervical RCT 0, 4 
years 
1890 women attending routine cervical smear 
test at one of 29 GP practices 
78-80% very low 
risk; 20-22% low 
risk 
Accuracy of risk perception, 21 short-
term outcome measures relating to 
knowledge and psychosocial 




Colorectal RCT 0 160 members of general public with no history 
of CRC or screening for CRC recruited through 
newspaper advertisements 










169 members of general public recruited through 
newspaper advertisements 
Mean lifetime risk 
7.78% (SD 1.13) 
Cancer worry M-H 
Lipkus, Breast RCT 0 121 members of general public recruited through Mean 10 year risk Negative affect related to getting M 
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Breast RCT 0 301 members of general public recruited through 
newspaper advertisements 
Mean lifetime risk 
8.5% 
(range 1.2 to 
30.5) 






Breast RCT 1 week 1235 women with scheduled appointments at an 
academic medical centre or hospital with no 
history of breast cancer 









59 female undergraduates with no first-degree 
relatives with breast cancer at one university 
Mean lifetime risk 
11.5% 





Breast RCT 1 month 299 women with no history of breast cancer 
attending outpatient mammography clinic 
Mean lifetime risk 
11.1% (SD 5.14) 
Accuracy of risk perception  M 
Rimer,  
2002 
Breast RCT 1 and 2 
years 
752 women aged 40-44 and 50-54 enrolled in a 
personal care plan 
Mean 10 year risk 
2.7% 
Accuracy of risk perception M-H 
Seitz, 2016  Breast RCT 0 2918 women aged 35–49 with no history of 
breast cancer or BRCA1 or BRCA2 mutation 
recruited through a survey company 
42 % had a 10 
year risk of 
<1.5% and 58% 
had a risk of 
>1.5%( mean 
2.53  SD 0.04)  
Accuracy of risk perception  M-H 
Sherratt, 
2016 
Lung  RCT 6 month 
follow 
up  
Participants were aged 18 to 60 years, and 
participants were excluded from the project if 
they had previously been diagnosed with lung 
cancer. 297 current and 216 recent former 
smokers aged 18– 60 years without a history of 
lung cancer and attending smoking cessation 
services 





RCT 0 612 members of general public with no history 
of cancer 
4.6% reported a 
history of cancer 





Colorectal RCT 1 month 314 patients recruited from 6 primary care 
practices without a history of colorectal cancer 




Breast,  RCT 0, 2 
weeks  
287 women aged 50-74 with no previous history 
of BC or diagnosis of increased BC risk, 





risk, 4% high risk 
Accuracy of risk perception, state and 
trait-anxiety and distress score related 











3786 patients from primary care clinics with no 
history of colon, breast or ovarian cancer invited 
by mail following record review 
82% moderate or 
strong risk for ≥1 
of the 6 
conditions 





0 353 patients with no history of cancer with 
scheduled routine or non-urgent health care 
visits at two primary care practices 
Below-average Accuracy of risk perception and 
accuracy of risk recall.  
L-M 
 
RCT – randomised controlled trial; CRC – colorectal cancer; CT computerised tomography 
* L – low, M – medium, H - high
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Table 2. Details of the risk-based interventions in each of the included studies 
Author, 
year 
Risk tool Intervention group(s) Comparison (where 
applicable) 
Format of risk 
Bowen 2006 Gail model (5 year, 
10 year and at age 
79) 
Four weekly 2-hour sessions led by a health counsellor 
focusing on risk assessment and education, screening, stress 
management and social support 
Delayed intervention No details given 
Bowen 2010 Gail model 
(lifetime) 
Information sheets with general information on breast cancer 
risk and personalised risk information plus telephone 
counselling and offer for more intensive group or genetic 
counselling 
Delayed intervention Bar graph of absolute lifetime risk along 
with age-appropriate estimates for the 
“average risk” woman 
Davis, 2004 BRCA tool 
(updated version of 
Gail model) 
(lifetime) 
10min brief intervention designed to increase accuracy of 
perceived risk including results of risk assessment and 
screening recommendations tailored to participant's stage of 
adoption of mammography and follow up written 
information 




Gail model (5 year 
and lifetime) 
Risk feedback sheet following completion of risk assessment 
questions plus kindness questionnaire or study calendar +/- 
additional questions about risk factors 
No intervention Absolute risk estimate as % and 
comparative estimate ranging from 'much 
lower' to 'much higher' along with a visual 
scale with risk estimate represented by a 
mark on the scale 
Dillard, 
2006b 
Gail model (5 year 
and lifetime) 
Risk feedback sheet including information on two other 
women and their risk factors as downward social comparison 
condition 
Risk feedback sheet Absolute risk estimate as % and 
comparative estimate ranging from 'much 
lower' to 'much higher' along with a visual 
scale with risk estimate represented by a 




Harvard cancer risk 
model (20 year) 
1) Absolute risk with active impact; 2) Absolute risk without 
active impact; 3) Absolute and relative risk with active 
impact; 4) Absolute and relative risk without active impact 
Passive risk 
communication but no 
absolute or relative risk 
estimates 
Absolute risk over 20 years +/- relative 
risk plus absolute risk +/- option to 
manipulate their risk factor profiles to see 
impact of changing risk factors on a visual 






Face-to-face or telephone intervention consisting of 8 items: 
1) a personal risk sheet ; 2) a personal computer-drawn 
pedigree; 3) a 23 page participant booklet; 4) Breast self-
examination brochure; 5) Pap smear and mammography 
No intervention Bar charts of absolute % risk with 
numerical % alongside for the individual, 




brochure; 6) BSE shower card; 7) pictures of chromosomes 




Wilkinson score  Brief 10 minute counselling session integrated with smear 
test appointment including relative and absolute risks and 
then negotiation of appropriate screening intervals 
Normal care Comparative and absolute risk in pictures 
and numbers 
Lipkus 2006 Not given Written information about CRC, CRC screening methods 
and CRC risk factors plus either 1) tailored CRC risk factor 
information or 2) tailored CRC risk factor information plus 
information on whether their total number of CRC risk 
factors  was greater or not than average 
Written information 
about CRC, CRC 
screening methods, and 
CRC risk factors 





1-2 page handout describing the Gail Model plus either 1) a 
point estimate of their risk; 2) a risk range derived from the 
95% confidence intervals; 3) a point estimate of their risk 
plus a risk range derived from the 95% confidence intervals 
No information As a percentage in a pie chart 
Lipkus, 
2001b 
Gail model (10 
year) 
1 page handout describing the Gail model plus absolute risk 
alone  
As for intervention 
group plus how their risk 
compared to a woman of 
their age and race at the 
lowest level of risk 
Absolute risk +/- risk of a woman at the 
lowest level of risk as percentages in a pie 
chart 
Lipkus, 2005 Gail model 
(lifetime) 
In three groups, women obtained information about their 
absolute risk only, in one of three formats. Three additional 
groups received their absolute risk in one of the three 
formats along with information about the risk of another 
woman the same age and race as the participant with no 
other risk factors 
No information Numerical percentages either 1) ‘‘point 
estimate condition’’ - single best point 
estimate of their risk as a percentage; 2) 
‘‘range condition’’ -  upper and lower 
bounds of risk as percentages; 3) "point 




Tool;  Gail Model; 
and Breast Cancer 
Surveillance 
Consortium model  
(5 year) 
Individually-tailored print-outs for patients and their 
physicians (one page in length) including specific risk 
reduction recommendations.  
No information Absolute risk as a percentage and 
comparative risk (higher/lower)  
McCaul, 
2003 
Gail model (5 year 
and lifetime) 
Printed feedback on two sheets including either absolute risk 
information, relative risk information, or both 
No information Absolute risk as a percentage and mark on 
two scales ranging from 0% to 100%. 
Comparative risk as a label (e.g., ‘Same’) 
and a mark on a scale ranging from ‘Much 
lower’ to ‘Much higher,’ with seven 
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labels including a centre label of ‘About 
the Same’ 
Quillin, 2004 Gail model (5 year 
and lifetime) 
Risk assessment with genetic counsellor then one-page 
summary including breast health messages that were 
appropriate for their calculated risk, including 
recommendations for screening, available genetic 
counselling, and contact information for psychosocial 
support 
No information Percentage risk alongside qualitative 
interpretation ("low", "moderate", high") 
and whether it is higher/lower than the 
average women's risk 
Rimer 2002 Gail model (10 year 
and lifetime) 
Tailored print booklet and brief tailored newspaper plus 
personalized risk 
Usual care (postcard 
reminder) 
Absolute risk as a percentage 
Seitz et al 
2016 
NCI BRCAT – 
based on the Gail 
model (10 year)  
Online risk plus basic information about mammography and 
national recommendations plus either (1) statements about 
women making choices, (2) untailored examples of women 
making choices or (3) examples of similar women making 
choices 
No information or the 
same basic information 
as intervention group 
All received Individualized 10-year and 
lifetime estimates of their objective risk 
for developing BC and the risk of an 
average-risk age-matched woman, all 
presented as both numeric frequencies and 
icon arrays.  
Sherrat et al 
2016 
Liverpool lung 
project risk model ( 
5 year at age 70)   
Personalised risk plus booklet stating the association 
between smoking and lung cancer and highlighting that 
quitting smoking was the best thing to do 
As for intervention but 
without personalised risk 
assessment 
Verbal and written absolute risk if 
continue to smoke and if stop smoking 




Kanker Risico Test 
(5 year) 
Participants were randomized to one of 12 experimental 
groups who received a combination of: 1) Average 
population risk (no quantitative risk information 
provided/only the number/number + graphic illustration); 2) 
the calculated personal risk (no quantitative information 
/numbers); and 3) the relative risk reduction after changing 
lifestyle (or no quantification of risk reduction) 
Standard version of the 
KWF-KRT 
12 different formats including numbers, 
graphical illustrations (emoticons and bar 
charts) of average population risk, 
personal risk and relative risk reduction 
Trevena 
2008 
No details given 20 page booklet including personalized risk, absolute 
reduction in colorectal cancer mortality with screening over 
the next 10 years, probability of test outcomes from 
screening and information about how to get screened. 









Patients given information that assigns them to 1 of 3 risk 
groups: high risk in need of genetic counselling, moderate 
risk in need of earlier screening or population risk. 
Statistical analysis used 
comparison between 
assigned risk groups  
Assignation to 1 of 3 risk groups: high, 
moderate or population. 
Wang, 2012 Family Healthware 
tool 
Written personalized prevention messages delivered via 
mail, e-mail, or in person tailored to familial risk for each of 
the six conditions alongside a family tree and information 
Standard print messages 
about screening and 
lifestyle choices via 
Qualitative risk - weak, moderate or 
strong familial risk 
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about the characteristics in one’s family history that put the 
person at increased risk (if applicable) 




Harvard cancer risk 
model (20 year) 
Absolute or relative risk electronically +/- the opportunity to 
manipulate the risk along with details of the risk factors that 
comprised their risk and recommendations for what they 
should change to reduce their risk 
Feedback on which of 
their behaviours and 
non-modifiable attributes 
lowered and which 
increased their risk and 
advice on steps they 
could take to lower their 
risk 
Absolute risk - numerical estimate in units 
of cases per thousand people like them 
alongside an oval window with the risk 
marked on a horizontal hairline. 
Comparative risk was expressed in terms 
of one of seven categories: ‘‘very much 
below average’’, ‘‘much below average,’’ 
‘‘below average,’’ ‘‘average’’, ‘‘above 
average,’’ ‘‘much above average,’’ and 
‘‘very much above average’’ alongside an 
oval window with the risk marked on a 
horizontal hairline 
 





Table 3. Summary of findings for accuracy of risk perception across the included studies. 
Author, 
year 
Definition of accuracy Time Main finding Effect 




Exactly the same 
number 
0 
Those who received both absolute and comparative risk estimates were more likely to have accurate 
absolute risk perceptions immediately post risk information (pooled RR 2.59 (1.40 to 4.81) I2=81.2%), with 




Within 0.5% 0 
Timmermans 
2012 
Within 2% 0 
Lipkus 2005 Within 5% 0 No difference between a control group and women who received either absolute or comparative risk 
information, with no effect of age, race or education 
↔ 
Rimer 2002 Within 10% 1 and 
2 
years 
Women were more likely to be accurate at follow-up if they had been accurate at baseline (OR=7.0 (4.9-
10.0), p<0.001); received tailored print materials including personalised breast cancer risk estimates plus 
telephone counselling vs control (OR=2.1 (1.4-3.3), p<0.001. There was no increase in accuracy among 
those who just received printed information compared with control (OR=1.0 (0.6-1.6), p=0.96). No 





Two groups - below 




No difference between a control group and one that received comparative risk information ([OR] = 0.98; 
[CI] = 0.72–1.33), % accurate at follow-up 70% control and 66% intervention, p = 0.11) ↔ 
Wang 2012 Two groups - below 




Among those who underestimated risk at baseline, a greater percentage of those who received their 
personalised risk increased their risk perceptions at the 6 month follow up compared to individuals in the 
control arm for colon cancer (17% vs 10%,OR 1.89 (0.99 to 3.59), p=0.05), but not for breast cancer or 




Three groups - below 
average, average and 
above average 
0 
No significant effect (pooled RR 1.11 (0.74 to 1.66) I2=82.9%) ↔ 
Lipkus 2005 Bias in comparative 
risk*  
0 
Quillin 2004 Two groups - below 




Significant change from baseline to follow-up from 78.7% (n=107) to 85.3% (n=99), p<0.01 
↑ 
Quillin 2004 Three groups – ‘usual’ 
risk for an estimated 
lifetime risk <15%, 
1 
month 
No significant change from baseline to follow-up (% accurate 65.2% (n=88) pre-intervention and 68.1% 
(n=77) post intervention, p = 0.46) ↔ 
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‘moderate’ risk for 15-
30% and ‘strong’ risk 
for >30% 
Overestimation as a measure of accuracy 





No difference (-2.7% in the control group (n=184) compared with -5.8% in the intervention group who 
received a 10-minute educational intervention over the telephone (n=183), p = 0.20). However, among 
women with a first-degree family history of breast cancer, those in the intervention group significantly 
reduced their risk overestimate compared to those in the control group (-12.5 vs. 2.8, p = 0.006). 
↔↑ 
Seitz 2016 The degree to which 
participants 
overestimated their risk 
0 Consistent improvement across six intervention groups when risk was measured as a percentage but not 
when risk was measured as a frequency out of 1000. For women with an estimated risk <1.5%, this effect 
was moderated by numeracy, with women with high numeracy having greater increases in accuracy than 
women with low numeracy. No significant moderation effects were seen for women with an estimated risk 
≥1.5%. 
↑ 
Indirect assessment of accuracy in populations who all overestimated risk at baseline 
Dillard 
2006a 
--- 0 The mean estimate of absolute risk among 72 undergraduate women decreased from 56.4% to 28.4% two 
weeks after absolute and comparative risk information. These, however, remained significantly higher than 
the estimated risk (mean 11.2% difference) p<0.01. No significant differences were seen among those who 
were asked to provide a pre-intervention risk estimate, those who were led to believe that all the factors they 
considered possibly responsible for their own breast cancer risk were used to compute their risk, or those 






Participants provided with their risk alone and those provided with their risk plus social comparison 
conditions reduced their risk estimates from pre-test to post-test, and maintained their new estimates at the 
2-week follow-up (pre-test mean 48.1% (SD 18) and 44.8% (SD 15.8) and post-test means 26.8% (SD 20.5) 
and 16.9% (SD 11.2) for those in a risk only and risk plus social comparison groups respectively). Their 






Women who received absolute risk reported both lower absolute risk perceptions (mean 34.9% compared 
with mean 52.1%, p<0.01) and lower comparative risk perceptions (mean 4.10 compared with mean 4.43, p 
= 0.05) immediately and at one week follow-up than women who did not. The effect for comparative risk 
information was not quite significant (p= 0.07) but women who received comparative risk estimates did 
report lower risk (mean 4.11) than those who did not (mean 4.43) 
↑ 
 
* Computed by first subtracting the participants’ personalised risk estimate from the risk estimate of the average same-aged woman with no risk factors, then subtracting participants’ 
estimates of their own and the average woman’s absolute numerical risk, and then comparing the two differences and categorising participants as accurate if the differences were within 5% 
36 
 
Table 4. Summary of findings for worry across the included studies. 
Author, 
year 
Measure of worry Main finding Effect 
Change from baseline to post-intervention   
Bowen 2006 Lerman four item cancer worry 
scale 
Significant decrease in worry among the group that received genetic counselling from 5.9 (SD 2.0) to 5.2 
(SD 1.5) at six months and 5.2 (SD 1.6) at two years (both p<0.001) 
↓ 
Helmes 2006 Lerman four item cancer worry 
scale 
Significant decrease (p<0.001) in worry among women who received both absolute and comparative risk 
information either in-person or telephone counselling when compared to a control group who received 
no information (the control arm decreased from 5.48 to 5.10, the in-person arm from 5.61 to 4.71, and 
the telephone arm from 5.50 to 4.68) 
↓ 
Davis 2004 12-point scale adapted from the 
Lerman scale 
No difference in the change in breast cancer worry from pre- to post-test between women who received  





5-point scale from ‘much more 
worried’ to ‘much less worried’ 
No increase in worry across any of  four intervention groups that received either absolute plus 
comparative risk or absolute risk alone with or without the option to manipulate the risk factors and see 
the impact of that on their risk. At follow-up 33% (n=116) reported being less worried about getting 
colorectal cancer and 17% (n=61), all of whom had perceived comparative risks of below average or 




Single question - ‘How concerned 
are you about getting breast 
cancer?’ 
No change in the proportion ‘very concerned’ from baseline to follow up among controls (22.3% vs 
22.0%, n=655) and a slight but non-significant decrease among women who received absolute and 
comparative risk information (27.1% vs 24.2%) (OR = 0.94, 95% CI 0.69–1.28) 
↔ 
Differences between groups post intervention  
McCaul 
2003 
Single question - ‘How worried are 
you about developing breast 
cancer?’ 
No significant difference in post-intervention worry adjusted for baseline worry immediately and one to 
two weeks after being provided with absolute risk information. A significant reduction in worry was 




Single question - ‘How often are 
you worried about lung cancer?’ 
No change in the proportion who were worried ‘Often or all the time’ compared to ‘Rarely or never’ at 
six months follow-up among those provided with absolute risk information compared with a control 
group both amongst current smokers (p=0.869) and recent ex-smokers (OR 2.18 95% CI 0.79-6.00, 
p=0.274) 
↔ 
Dillard 2006 Single question - ‘How worried are 
you about developing breast 
cancer?’ 
No significant differences were found between women who were asked to provide a pre-intervention 
risk estimate, those who were led to believe that all the factors they considered possibly responsible for 
their own breast cancer risk were used to compute their risk, or those who completed a self-affirmation 





Percentage who agreed or disagreed 
with the statement ‘I am more 
worried now about my risk of 
After receiving a combination of information on average population risk, personal risk and the relative 
risk reduction after changing lifestyle, 55.4% of participants disagreed with the statement for colon 




cancer than before I did my cancer 
risk test’ 
respectively, indicating that worry had stayed the same or reduced in most individuals 
Lipkus 2005 Combined responses to three 
questions about how worried, 
fearful and anxious they were about 
developing breast cancer 
No difference between participants provided with either no risk information or absolute or absolute plus 
comparative risk information and no effect of age, race or education 
↔ 
Lipkus 2006 Combined responses to three 
questions about how worried, 
fearful and anxious they were about 
developing breast cancer 
No difference between participants provided with either no risk information or absolute or absolute plus 
comparative risk information but those told that they “did not have more than the average number of risk 
factors” had lower combined worry, anxiety and fear at follow-up than those told that they had more 
than the average number (mean at follow-up adjusted for baseline 5.60 for low comparative information 
compared with 6.38 for high comparative information) 
↔ 
Lipkus 2001 Combined responses to three 
questions about how worried, 
fearful and anxious they were about 
developing breast cancer 





Individual questions includng – 
‘How anxious are you about your 
recent smear test?’; ‘How 
concerned are you about the chance 
of serious problems with your smear 
test in the future?’; and ‘How fearful 
are you of cervical cancer?’ 
Women in intervention practices were significantly less likely to be “anxious about recent smear test” 
(OR: 0.81 (95%CI: 0.66 to 0.98)), “concerned about chances of serious problems with smear test in the 
future” (OR: 0.70 (95%CI: 0.51 to 0.95)), “fearful of cervical cancer” (OR: 0.66 (95%CI: 0.47 to 0.93)) 
↓ 
 
Papers before duplicates removed
(n = 38,906)
Papers screened






Full-text papers excluded, with reasons
(n = 180)
No provision of risk information – 69
No relevant outcome data – 32
Conference abstract - 20
Not primary research - 16
Patients recruited following referral – 14
Hypothetical scenarios - 8
Risk based on genetic information - 8
Risk based on only one variable – 6
Unable to separate data on cancer – 3
Duplicate data – 2
Not peer reviewed - 1
Unavailable - 1







Additional papers identified 








NOTE: Weights are from random effects analysis












Percentage able to recall absolute risk immediately




















Subtotal  (I-squared = 82.2%, p = 0.018)




























1.05 .1 .2 .5 50 100
Relative risk of having an accurate perception of risk





Overall (I2 = 85.5%)












Subtotal  (I-squared = 0.0%, p = 0.357)






















146/350Overall (I2 = 0%)
Overall (I2 = 94.3%)
25 7550
Figure 4
Appendix File A.1 – Complete search strategy 
 
Medline and Cinahl 
S28 S26 NOT S27  
S27 review  
S26 S24 AND S25  
S25 S13 NOT S15  
S24 S14 OR S16 OR S17 OR S21 OR S22 OR S23  
S23 ( behaviour OR behavior ) AND health  
S22 (MH "Health Behavior+") OR (MH "Risk Reduction Behavior+")  
S21 S18 OR S20  
S20 S19 AND S1  
S19 screen* AND uptake OR attendance OR intention OR adherence  
S18 (MM "Early Detection of Cancer/UT")  
S17 anxiety* OR worry* OR denial* OR hopelessness* OR avoidance*  
S16 efficacy OR effectiv*  
S15 PT review OR PT letter OR PT comment OR PT editorial  
S14 percep* OR perceive* OR understand* OR understood* OR accura* OR comprehen*  
S13 S9 NOT S12  
S12 S10 OR S11  
S11 (MH "Prognosis+")  
S10 prognos* OR treatment* OR surgery*  
S9 S1 AND S8  
S8 S6 OR S7  
S7 (MH "Risk Assessment+")  
S6 S4 AND S5  
S5 score* OR model* OR predict* OR tool*  
S4 S2 OR S3  
S3 (MH "Risk+")  
S2 risk*  
S1 "cancer" OR (MH "Neoplasms+") 
 
Embase 
1 cancer.mp. or exp neoplasm/ 
2 exp risk/ or risk*.mp. 
3 (score* or model* or predict* or tool*).mp. [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] 
4 2 and 3 
5 exp risk assessment/ 
6 4 or 5 
7 1 and 6 
8 (percep* or perceive* or understand* or understood* or accura* or comprehen*).mp. 
[mp=title, abstract, heading word, drug trade name, original title, device manufacturer, 
drug manufacturer, device trade name, keyword] 
9 (efficacy* or effectiv*).mp. [mp=title, abstract, heading word, drug trade name, original 
title, device manufacturer, drug manufacturer, device trade name, keyword] 
10 exp prognosis/ 
11 (prognos* or treatment* or surgery*).mp. [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] 
12 (review or letter or comment or editorial).pt. 
13 (radiotherapy* or stage* or grade*).mp. [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] 
14 (anxiety* or worry* or fatalism* or hopelessness* or denial* or avoid*).mp. [mp=title, 
abstract, heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
15 8 or 9 or 14 
16 10 or 11 or 12 or 13 
17 exp cancer screening/ 
18 health behaviour.mp. or exp health behavior/ 
19 ((behaviour or behavior) and health).mp. [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] 
20 (screen* and (uptake or attendance or intention or adherence)).mp. [mp=title, abstract, 
heading word, drug trade name, original title, device manufacturer, drug manufacturer, 
device trade name, keyword] 
21 20 and 1 
22 15 or 17 or 18 or 19 or 21 
23 22 and 7 
24 23 not 16 
25 limit 24 to yr="2000 -Current" 
26 25 not review.mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword] 
 
PsycInfo 
S20 S19 NOT review  Limiters - Publication Year: 2000-2017 
S19 S17 NOT (S10 OR S11 OR S12)  
S18 S17 NOT (S10 OR S11 OR S12)  
S17 S7 and (S8 or S9 or S13 or S15 or S16)  
S16 health AND (behaviour OR behavior)  
S15 S14 AND S1  
S14 screen* AND (uptake OR attendance OR intention OR adherence)  
S13 MM "Cancer Screening"  
S12 (prognos* OR treatment* OR surgery*) AND (S10 OR S11)  
S11 prognos* OR treatment* OR surgery*  
S10 DE "Prognosis"  
S9 efficacy or effectiv* or worry* or anxiety* or hopelessness* or denial*  
S8 percep* OR perceive* OR understand* OR understood* OR accura* OR comprehen*  
S7 (S1 AND S6)  
S6 (S4 OR S5)  
S5 DE "Risk Assessment"  
S4 (S2 AND S3)  
S3 score* OR model* OR predict* OR tool*  
S2 risk*  
S1 DE "Neoplasms" OR DE "Benign Neoplasms" OR DE "Breast Neoplasms" OR DE 
"Endocrine Neoplasms" OR DE "Leukemias" OR DE "Nervous System Neoplasms" OR 
DE "Terminal Cancer" 
 
 
Appendix File A.2.  Quality assessment of included studies 
 

































2006 ● ● ● ● ● ● ● n/a H 
Bowen  
2010 ● ● ● ● ● ● ● n/a H 
Davis,  
2004 ● ● ● ● ● ● ● n/a M 
Dillard,  
2006a ● ● ● ● ● ● ● n/a L-M 
Dillard,  
2006b ● ● ● ● ● ● ● n/a L-M 
Emmons, 
2004 ● ● ● ● ● ● n/a n/a M-H 
Helmes,  
2006 ● ● ● ● ● ● ● n/a M-H 
Holloway, 
2003 ● ● ● ● ● ● ● n/a H 
Lipkus , 
2006 ● ● ● ● ● ● n/a n/a M 
Lipkus,  
2001a ● ● ● n/a ● n/a ● ● M-H 
Lipkus,  
2001b ● ● ● n/a ● n/a n/a ● M 
Lipkus,  
2005 ● ● ● n/a ● n/a n/a ● M 
Livaudais-
Toman, 2015 ● ● ● ● ● ● ● n/a H 
McCaul,  
2003 ● ● ● ● ● ● ● n/a M 
Quillin,  
2004 ● ● ● ● ● ● ● n/a M 
Rimer, 
2002 ● ● ● ● ● ● ● n/a M-H 
Seitz, 
 2016 ● ● ● ● ● ● n/a n/a M-H 
Sherrat, 
 2016 ● ● ● ● ● ● ● n/a H 
Timmermans 
2012 ● ● ● ● ● ● n/a n/a M 
Trevena  
2008 ● ● ● ● ● ● ● n/a M-H 
van Erkelens, 
2017 ● ● ● ● ● ● ● n/a L-M 
Wang,  
2012 ● ● ● ● ● ● ● n/a H 
Weinstein, 
2004 ● ● ● ● ● ● n/a n/a L-M 
●  Low (L)   ●  Medium (M)    ●   High  (H) 
 
